Jeffrey D Randall

This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent. Top assignees: Quanterix Corporation, US Genomics, Inc.. Active years: 2007-2026.

USPTO Granted Patents = 8 (Patent Applications = 6)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 224(Granted Patents)

Company Filing History:

6 out of 29

Quanterix Corporation

Years Active: 2007-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12571803 - Methods of producing bodily fluid samples containing an analytically quantified amount of phosphorylated tau protein (2026-03-10),

2. 12540950 - Methods of assaying phosphorylated tau protein in a sample (2026-02-03),

3. 11275092 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2022-03-15),

4. 10393759 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2019-08-27),

5. 8846415 - Ultra-sensitive detection of molecules on single molecule arrays (2014-09-30),

6. 8222047 - Ultra-sensitive detection of molecules on single molecule arrays (2012-07-17),

7. 7371520 - Methods and apparati using single polymer analysis (2008-05-13),

8. 7282330 - Methods and apparati using single polymer analysis (2007-10-16),

Title: Biography of Inventor Jeffrey D Randall

Introduction: Jeffrey D Randall is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of brain injury recovery.

Latest Patents: Jeffrey holds six patents, with his latest invention focusing on methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. This invention addresses the assessment of brain injuries resulting from hypoxic events and includes methods for measuring the concentration of tau protein in patient samples.

Career Highlights: Throughout his career, Jeffrey has worked with prominent companies in the medical technology sector, including Quanterix Corporation and US Genomics, Inc. His work has been instrumental in advancing diagnostic methods and treatment protocols for brain injuries.

Collaborations: Jeffrey has collaborated with esteemed colleagues such as David C Duffy and Evan Ferrell. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion: Jeffrey D Randall's work exemplifies the impact of innovation in healthcare. His inventions continue to pave the way for improved treatment options for patients recovering from brain injuries.